Genomic Portraits: Reflections into a tumor's response to therapy.

Well-annotated matched tissue specimens both prior to and after initiation of androgen receptor signaling inhibitors (ARSIs) have revealed activation of unique signaling pathways and genomic signatures that identify a profile to guide therapy. A recent study represents the largest prospective biospecimen banking protocol to study mechanisms of resistance to ARSIs.